Effects of neocarzinostatin - Chimeric Fab conjugates on the growth of human pancreatic carcinoma xenografts

British Journal of Cancer

Volumn 73, Issue 10, 1996, Pages 1178-1182

  Otsuji, E ^a   Yamaguchi, T ^a   Tsuruta, H ^a   Yata, Y ^a   Nishi, H ^a   Okamoto, K ^a   Taniguchi, K ^a   Kato, M ^a   Kotani, T ^a   Kitamura, K ^a   Takahashi, T ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Chimeric antibody; Monoclonal antibody; Neocarzinostatin; Pancreatic cancer; Targeting chemotherapy

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; ZINOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; COVALENT BOND; DOSE RESPONSE; DRUG EFFECT; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; XENOGRAFT;

EID: 9344265213     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.227     Document Type: Article

References (29)

1. APELGREN LD, ZIMMERMAN DL, BRIGGS SL AND BUMOL TF. (1990). Antitumor activity of monoclonal antibody - Vinca alkaloid immunoconjugate LY203725 (KS1/4-4-desacetylvinblastine-3-carboxhydrazide) in a nude mouse model of human ovarian cancer. Cancer Res., 50, 3540-3544.
2. BLOTTIERE HM, MAUREL C AND DOUILLARD JY. (1987). Immune function of patients with gastrointestinal carcinoma after treatment with multiple infusions of monoclonal antibody 17.1A. Cancer Res., 47, 5238-5241.
3. BOULIANNE GL, HOZUMI N AND SCHULMAN MJ. (1984). Production of functional chimeric mouse/human antibody. Nature, 312, 643-646.
4. DEGUCHI T, MING C, SUSAN SL, JURIUS SH AND LEE C. (1987). Potential therapeutic effect of adriamycin-monoclonal antiprostatic acid phosphatase antibody conjugate on human prostate tumor. J. Urol., 137, 353-358.
5. FRODIN JE, BIBERFELD P, CHRISTENSSON B, PHILSTEDT P, SUDELIUS S, SYLVEN M, WAHREN B, KOPROWSKI H AND MELLSTEDT H. (1986). Treatment of patients with metastasizing colo-rectal carcinoma with mouse monoclonal antibodies: a progress report. Hybridoma, 5, S151-S161.
6. FUJITA H, NAKAYAMA N, SAWABE T AND KIMURA K. (1970). In vivo distribution and inactivation of neocarzinostatin. Jpn. J. Antibiotics, 23, 471-478.
7. FUKUDA K. (1985). The study of targeting chemotherapy against gastrointestinal cancer. Akita J. Med., 12, 451-468.
8. HASPEL MV, MCCABE RP, POMATO N, JANESCH NJ, KNOWLTON JV, PETERS LC, HOOVER HC JR AND HANNA MG JR. (1985). Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal patients. Cancer Res., 45, 3951-3961.
9. HOOGENBOOM HR AND WINTER G. (1992). By-passing immunisation. Human antibodies from synthetic repertories of germline VH gene segments rearranged in vitro. J. Mol. Biol., 20, 381-388.
10. JUNG G, KOHNLEIN W AND LUDERS G (1981). Biological activity of the antitumor protein neocarzinostatin coupled to a monoclonal antibody by N-succinimidyl 3-(2-pyridyldithio)-propionate. Biochem. Biophys. Res. Commun., 101, 599-606.
11. KIMURA I, OHNISHI T, TSUBOTA T, SATO Y, KOBAYASHI T AND ABE S. (1980). Production of tumor antibody - neocarzinostatin conjugate and its biological activities. Cancer Immunol. Immunother., 7, 235-242.
12. LOBUGLI AF, SALEH M, PETERSON L, WHEELER R, CARRANO R, HUSTER W AND KHAZAELI MB. (1986). Phase I clinical trial of CO17-1A monoclonal antibody. Hybridoma, 5, S117-S123.
13. MCCABE RP, PETERS LC, HASPEL MV, POMATO N, CARRASQUILLO JA AND HANNA MG JR. (1988). Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors. Cancer Res., 48, 4348-4353.
14. MORRISON SL, JOHNSON MJ, HERZENBERG LA AND OI VT. (1984). Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc. Natl. Acad. Sci. USA, 81, 6851-6855.
15. NAPIER MA, KAPPEN LS AND GOLDBERG IH. (1989). Effect of nonprotein chromophore removal on neocarzinostatin action. Biochemistry, 19, 1767-1773.
16. OHTSUKI K AND ISHIDA N. (1980). The biological effect of a nonprotein component removed from neocarzinostatin (NCS). J. Antibiot., 33, 744-750.
17. OHYANAGI H, ISHIDA H, ISHIDA T, SOYAMA N, YAMAMOTO M, OKUMURA S, KANO Y, UEDA Y AND SAITOH Y. (1988). A monoclonal antibody, KM10, reactive with human gastrointestinal cancer and its application for immunotherapy. Jpn. J. Cancer Res., 79, 1349-1358.
18. OKABAYASHI K, NAKAGAWA Y, HAYASUKE N, OHI H, MIURA M, ISHIDA Y, SHIMAZU M, MURAKAMI K, HIRABAYASHI K, MINATOMI H, HORII H, MASAKI A, SUMI A, OHMURA T AND KAWABE H. (1991). Secretory expression of the human serum albumin gene in the yeast, Saccharomyces cerevisiae. J. Biochem., 110, 103-110.
19. OTSUJI E, TAKAHASHI T, YAMAGUCHI T, YAMAGUCHI N AND IMANISHI J. (1990). Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma. Gastroenterol. Jpn., 25, 244-248.
20. OTSUJI E, YAMAGUCHI T, YAMAGUCHI N, KOYAMA K, IMANISHI J, YAMAOKA N AND TAKAHASHI T. (1992). Expression of the cell surface antigen detected by the monoclonal antibody A7 in pancreatic carcinoma cell lines. Surg. Today, 22, 351-356.
21. OTSUJI E, YAMAGUCHI T, YAMAOKA N, KITAMURA K, YAMAGUCHI N, IMANISHI J AND TAKAHASHI T. (1993a). Increased antitumor effect of neocarzinosatatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma grafted in nude mice. Antibody, Immunoconj. Radiopharm., 6, 177-183.
22. OTSUJI E, YAMAGUCHI T, YAMAOKA N, KATO M, KOTANI T, KITAMURA K, YAMAGUCHI N AND TAKAHASHI T. (1993b). Enhanced tumor localization of radiolaheled Fab fragments of monoclonal antibody A7 in nude mice bearing human pancreatic carcinoma xenografts. Jpn. J. Cancer Res., 84, 914-920.
23. OTSUJI E, YAMAGUCHI T, YAMAOKA N, TANIGUCHI K, KATO M, KOTANI T, KITAMURA K AND TAKAHASHI T. (1994a). Biodistribution of neocarzinostatin conjugated to chimeric Fab fragments of the monoclonal antibody A7 in nude mice bearing human pancreatic cancer xenografts. Jpn. J. Cancer Res., 85, 530-535.
24. OTSUJI E, YAMAGUCHI T, YATA Y, NISHI H, OKAMOTO K, TANIGUCHI K, KATO M, KOTANI T, YAMAOKA N, KITAMURA K AND TAKAHASHI T. (1994b). Antitumor effect of neocarzinostatin conjugated to human/mouse chimeric Fab fragments of the monoclonal antibody A7 on human pancreatic carcinoma. J. Surg. Oncol., 57, 230-234.
25. SPIEGELBERG HL AND WEIGLE WO. (1965). The catabolism of homologous and heterologous 7s gamma globulin fragments. J. Exp. Med., 121, 323-338.
26. SUTHERLAND R, BUCHEGGER F, SCHREYER M, VACCA A AND MACH JP. (1987). Penetration and binding of radiolabeled anticarcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Cancer Res., 47, 1627-1633.
27. TAKAHASHI T, YAMAGUCHI T, KITAMURA K, NOGUCHI A, HONDA M AND OTSUJI E. (1993). Follow-up study of patients treated with monoclonal antibody - drug conjugate: report of 77 cases with colorectal cancer. Jpn. J. Cancer Res., 84, 976-981.
28. WEIDEN PL, WOLF SB, BREITZ HB, APPELBAUM JW, SEILER CA, MALLETT R, BJORN MJ, SU FM, FER MF AND SALK D. (1994). Human anti-mouse antibody suppression with cyclosporin A. Cancer, 73, 1093-1097.
29. YAMAGUCHI T, TSURUMI H, KITAMURA K, OTSUJI E, MIYAGAKI T, KOTANI T AND TAKAHASHI T. (1993). Production, binding and cytotoxicity of human/mouse chimeric monoclonal antibody neocarzinostatin conjugate. Jpn. J. Cancer Res., 84, 1190-1194.